BioScrip, Inc.(BIOS): For the most recent quarter end, BioScrip, Inc. reported Annual Earnings of $-0.1. Based on the filings, last years Annual Earnings was, $-0.95. For the most recent quarter end, BIOS reported a surprise Earnings per Share of -66.67% . The consensus estimate for current quarter is $-0.08 and for the current fiscal year, the estimate is $-0.43. For the Next fiscal year, the estimate is $-0.22 based on the consensus.
BioScrip, Inc. has received $-0.08 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 3 Financial Advisor in the Stock Trading Firms. Among 3 Analysts, Bottom line EPS Estimate for the current quarter is $-0.11 while the top line estimate is $-0.06 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 46.67%. BioScrip, Inc. results fell short with a surprise EPS of -66.67% or $-0.04. The Actual EPS was $-0.1 compared to the Estimated EPS of $-0.06 during its most recent quarterly earnings.
BioScrip Inc Last issued its quarterly earnings results on Nov 7, 2016. The company reported $-0.12 EPS for the quarter, missing the analyst consensus estimate by $ -0.07. Analyst had a consensus of $-0.05. The company had revenue of $224.50 million for the quarter, compared to analysts expectations of $223.28 million. The companys revenue was down -9.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.38 EPS.
Company has reported several Insider transactions to the SEC, on Nov 14, 2016, Jeffrey M Kreger (CFO) purchased 10,000 shares at 1.32 per share price.On Nov 14, 2016, Daniel E Greenleaf (CEO) purchased 16,000 shares at 1.30 per share price.On Nov 14, 2016, R Carter Pate (director) purchased 20,000 shares at 1.30 per share price.
BioScrip, Inc. (NASDAQ:BIOS) rose 1.25% or 0.02 points on Wednesday and made its way into the gainers of the day. After trading began at $1.6 the stock was seen hitting $1.64 as a peak level and $1.58 as the lowest level. The stock ended up at $1.62. The daily volume was measured at 1,102,673 shares. The 52-week high of the share price is $3.43 and the 52-week low is $0.98. The company has a market cap of $191 million.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services, both nationally and community-based and pharmacy benefit management services.